Manage episode 279438311 series 2511131
With several vaccines on the way, 2021 promises to be a great year for equities. Earnings could reach double-digit growth and the trend of underperformance in value stocks could grind to a hold, say Jeroen Blokland and Peter van der Welle in our latest podcast episode. It’s also a time for non-US stocks to outperform their US equivalents. Tune in to hear it all.